Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paciltaxel Alone or in Combination with Bevacizumab followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum- Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer
IRB GOG0213
CC CC444
Hospital Fairview, Hillcrest, Main Campus
Stage Recurrent/Relapsed
Phase Phase 3
Disease Fallopian Tube, Gynecologic, Ovarian, Peritoneal
Drug Bevacizumab , Carboplatin, Paclitaxel
